The results provided by Tomé‐Carneiro et al. found that supplementation with a grape extract containing resveratrol modulates inflammation‐related miRs (miR‐155, miR‐21, miR‐181b, and miR‐34a) and pro‐inflammatory cytokines (CCL3, IL‐1β and TNF‐α) in peripheral blood mononuclear cells of patients with T2DM. This evidence concerns the gene IL1B and type 2 diabetes mellitus.